These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1379513)

  • 1. Disposition characteristics of macromolecules in the perfused tissue-isolated tumor preparation.
    Imoto H; Sakamura Y; Ohkouchi K; Atsumi R; Takakura Y; Sezaki H; Hashida M
    Cancer Res; 1992 Aug; 52(16):4396-401. PubMed ID: 1379513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of anticancer drugs after bolus arterial administration in a tissue-isolated tumor perfusion system.
    Ohkouchi K; Imoto H; Takakura Y; Hashida M; Sezaki H
    Cancer Res; 1990 Mar; 50(5):1640-4. PubMed ID: 2105843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection.
    Nomura T; Saikawa A; Morita S; Sakaeda Kakutani T; Yamashita F; Honda K; Takakura Y; Hashida M
    J Control Release; 1998 Mar; 52(3):239-52. PubMed ID: 9743445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition characteristics of model macromolecules in the perfused rat kidney.
    Mihara K; Mori M; Hojo T; Takakura Y; Sezaki H; Hashida M
    Biol Pharm Bull; 1993 Feb; 16(2):158-62. PubMed ID: 7689886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.
    Nishida K; Mihara K; Takino T; Nakane S; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1991 Apr; 8(4):437-44. PubMed ID: 1714579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits.
    Atsumi R; Endo K; Kakutani T; Takakura Y; Hashida M; Sezaki H
    Cancer Res; 1987 Nov; 47(21):5546-51. PubMed ID: 2444332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.
    Sato K; Itakura K; Nishida K; Takakura Y; Hashida M; Sezaki H
    J Pharm Sci; 1989 Jan; 78(1):11-6. PubMed ID: 2468759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran.
    Hashida M; Atsumi R; Nishida K; Nakane S; Takakura Y; Sezaki H
    J Pharmacobiodyn; 1990 Jul; 13(7):441-7. PubMed ID: 1705289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and tumor localization of mitomycin C-dextran conjugates in mice.
    Takakura Y; Takagi A; Hashida M; Sezaki H
    Pharm Res; 1987 Aug; 4(4):293-300. PubMed ID: 2470072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary permeability of sulphate-substituted and neutral dextran fractions in the rat hindquarter vascular bed.
    Haraldsson B; Moxham BJ; Rippe B
    Acta Physiol Scand; 1982 Aug; 115(4):397-404. PubMed ID: 6184948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
    Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
    Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
    [No Abstract]   [Full Text] [Related]  

  • 12. Disposition characteristics of macromolecules in tumor-bearing mice.
    Takakura Y; Fujita T; Hashida M; Sezaki H
    Pharm Res; 1990 Apr; 7(4):339-46. PubMed ID: 1694582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular interaction and in vitro antitumor activity of mitomycin C-dextran conjugate.
    Matsumoto S; Yamamoto A; Takakura Y; Hashida M; Tanigawa N; Sezaki H
    Cancer Res; 1986 Sep; 46(9):4463-8. PubMed ID: 2425952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.
    Onishi H; Machida Y
    Molecules; 2008 Aug; 13(9):2136-55. PubMed ID: 18830146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and pharmacokinetics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the rat.
    Hashida M; Kato A; Takakura Y; Sezaki H
    Drug Metab Dispos; 1984; 12(4):492-9. PubMed ID: 6148218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.
    Saikawa A; Nomura T; Yamashita F; Takakura Y; Sezaki H; Hashida M
    Pharm Res; 1996 Oct; 13(10):1438-44. PubMed ID: 8899832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
    Jain RK; Baxter LT
    Cancer Res; 1988 Dec; 48(24 Pt 1):7022-32. PubMed ID: 3191477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral pharmacokinetics of oligonucleotides in a tissue-isolated tumor perfusion system.
    Nakajima S; Koshino Y; Nomura T; Yamashita F; Agrawal S; Takakura Y; Hashida M
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):105-10. PubMed ID: 10805161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.
    Baxter LT; Jain RK
    Microvasc Res; 1991 Jan; 41(1):5-23. PubMed ID: 2051954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of drug delivery systems for macromolecular drugs].
    Takakura Y
    Yakugaku Zasshi; 1996 Jul; 116(7):519-32. PubMed ID: 8831257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.